Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL320232 | 0.98 | LMNA (0.48) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL31683702 | 0.98 | LMNA (0.48) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL30531662 | 0.98 | LMNA (0.48) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL7960059 | 0.95 | LMNA (0.47) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Lactic Acid SCHEMBL28460211 | 0.91 | TP53 (0.46) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Hexadecane SCHEMBL28029400 | 0.86 | KDM4E (0.67) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL3635596 | 0.84 | LMNA (0.48) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL4729415 | 0.84 | KDM4E (0.42) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Butyric Acid SCHEMBL27902376 | 0.83 | KDM4E (0.50) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Citric Acid SCHEMBL30003489 | 0.80 | ALDH1A1 (0.48) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105247030-A | Preparation of lactate esters directly from oil | PURAC BIOCHEM BV | 2016-01-13 | — | — | CN | disclosed |
| CN-102050723-B | Method for producing sodium lactate | CHINA PETROLEUM & CHEMICAL | 2013-06-19 | — | — | CN | disclosed |
| CN-102050723-A | Method for producing sodium lactate | CHINA PETROLEUM & CHEMICAL | 2011-05-11 | — | — | CN | disclosed |
| US-7427397-B2 | Probiotic propionibacterium | UNIVERSITY OF NEWCASTLE RESEARCH ASSOCIATES (TUNRA) LTD. (AU) | 2008-09-23 | — | — | US | disclosed |
| EP-1527159-A4 | PROBIOTIC PROPIONIBACTERIUM JENSENII 702 | UNIV NEWCASTLE RES ASS (AU) | 2006-10-04 | — | — | EP | disclosed |
| US-20050180963-A1 | Probiotic propionibacterium | UNIVERSITY OF NEWCASTLE RESEARCH ASSOCIATES (TUNRA) LTD. | 2005-08-18 | — | — | US | disclosed |
| EP-1527159-A1 | PROBIOTIC PROPIONIBACTERIUM JENSENII 702 | THE UNIVERSITY OF NEWCASTLE RESEARCH ASSOCIATES LIMITED (AU) | 2005-05-04 | — | — | EP | disclosed |
| WO-2004001022-A1 | PROBIOTIC PROPIONIBACTERIUM JENSENII 702 | THE UNIVERSITY OF NEWCASTLE RESEARCH ASSOCIATES (TUNRA) LTD (AU) | 2003-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050180963-A1 | Probiotic propionibacterium | FOLH1, FBP1, GUSB | LMNA 1583/4885KDM4E 4633/4885DUSP3 3173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.